StockData
Q32 Bio Inc. logo

Q32 Bio Inc. (QTTB) income statement

QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.48−0.05 (-0.59%)

Close on Nov 19, 2026Market cap $252.45MP/E –Yield –

Q32 Bio Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
39.9%
Net margin
62.9%
Return on equity, FY2025
125.1%

Financial strength

Current ratio
20.30
Debt to equity
–
Debt to assets
–
Cash to current liabilities
1967.6%

Valuation

P/E ratio
–
Price to sales
–
Price to book
2.38
Dividend yield
–

See a number that looks wrong?